OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
IPE56

Ipopema Securities SA

Investment Banking & Brokerage ServicesVerified

Ipopema Securities SA has a liquidity profile that is currently rated as medium, with a debt-to-equity ratio of 0.64, indicating a moderate level of leverage. The company's free cash flow is relatively low at 1,095,000 PLN, and its capital expenditure is negative at -1,449,000 PLN, suggesting a reduction in capital spending or asset disposals. The company's return on equity is 1.2%, and its return on assets is 0.22%, both of which are below the typical performance benchmarks for the investment banking and brokerage services industry. In terms of profitability, Ipopema's operating income of 1,582,000 PLN and net income of 1,470,000 PLN reflect a modest level of earnings relative to its total assets of 675,004,000 PLN. The company's return on equity and return on assets are below the industry median, indicating that it is not generating returns as efficiently as its peers. This may be due to a combination of lower revenue growth and higher operating costs. Ipopema's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risk in the event of a downturn in its primary market or sector. The company's growth trajectory is not clearly defined in the available data, as there are no specific projections or outlooks provided for the current or next fiscal year. However, the modest net income and low free cash flow suggest that the company may be facing challenges in sustaining growth or expanding its operations. The risk assessment for Ipopema indicates a medium liquidity risk and a low dilution risk. The company's key financial flag is a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. There is no indication of significant dilution pressure in the near term, and the company's capital structure appears to be relatively stable. Recent events and filings for Ipopema are not detailed in the available data, but the company's financial performance and risk profile suggest that it may be underperforming relative to its peers in the investment banking and brokerage services industry. Investors should monitor the company's financial statements and any future disclosures for signs of improvement or deterioration in its business performance.

30-day price · IPE+1.78 (+34.5%)
Low$4.90High$6.98Close$6.94As of13 May, 00:00 UTC
Profile
CompanyIpopema Securities SA
TickerIPE.WA
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Banking & Brokerage Services
AI analysis

Business. Ipopema Securities SA provides investment banking and brokerage services in the financial sector, generating revenue primarily through trading, asset management, and advisory services.

Classification. Ipopema is classified under the industry "Investment Banking & Brokerage Services" within the "Banking & Investment Services" business sector, with a confidence level of 0.92.

Ipopema Securities SA has a liquidity profile that is currently rated as medium, with a debt-to-equity ratio of 0.64, indicating a moderate level of leverage. The company's free cash flow is relatively low at 1,095,000 PLN, and its capital expenditure is negative at -1,449,000 PLN, suggesting a reduction in capital spending or asset disposals. The company's return on equity is 1.2%, and its return on assets is 0.22%, both of which are below the typical performance benchmarks for the investment banking and brokerage services industry. In terms of profitability, Ipopema's operating income of 1,582,000 PLN and net income of 1,470,000 PLN reflect a modest level of earnings relative to its total assets of 675,004,000 PLN. The company's return on equity and return on assets are below the industry median, indicating that it is not generating returns as efficiently as its peers. This may be due to a combination of lower revenue growth and higher operating costs. Ipopema's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risk in the event of a downturn in its primary market or sector. The company's growth trajectory is not clearly defined in the available data, as there are no specific projections or outlooks provided for the current or next fiscal year. However, the modest net income and low free cash flow suggest that the company may be facing challenges in sustaining growth or expanding its operations. The risk assessment for Ipopema indicates a medium liquidity risk and a low dilution risk. The company's key financial flag is a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. There is no indication of significant dilution pressure in the near term, and the company's capital structure appears to be relatively stable. Recent events and filings for Ipopema are not detailed in the available data, but the company's financial performance and risk profile suggest that it may be underperforming relative to its peers in the investment banking and brokerage services industry. Investors should monitor the company's financial statements and any future disclosures for signs of improvement or deterioration in its business performance.
Key takeaways
  • Ipopema has a moderate level of leverage with a debt-to-equity ratio of 0.64.
  • The company's return on equity and return on assets are below industry benchmarks.
  • Ipopema's revenue is concentrated in a single business segment, increasing its exposure to market risks.
  • The company's liquidity risk is rated as medium, with a negative net cash position after subtracting total debt.
  • There is no indication of significant dilution pressure in the near term.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyPLN
Revenue$66.2M
Gross profit
Operating income$1.6M
Net income$1.5M
R&D
SG&A
D&A
SBC
Operating cash flow$291.2M
CapEx-$1.4M
Free cash flow$1.1M
Total assets$675.0M
Total liabilities$552.7M
Total equity$122.3M
Cash & equivalents
Long-term debt$78.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$256.4M$18.5M$13.1M$7.1M
FY-3$260.1M$5.7M$5.5M$1.1M
FY-2$324.2M$24.9M$18.2M$18.9M
FY-1$257.1M$11.9M$9.1M$3.7M
FY0$296.9M$29.6M$23.9M$22.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$420.9M$111.0M$92.7M
FY-3$379.7M$107.2M
FY-2$420.8M$120.7M
FY-1$362.1M$120.9M
FY0$475.3M$135.6M
PeriodOCFCapExFCFSBC
FY-4-$146.2M-$1.2M$7.1M
FY-3$45.4M-$2.1M$1.1M
FY-2$23.5M-$1.4M$18.9M
FY-1$55.8M-$2.0M$3.7M
FY0$25.1M-$670.0k$22.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$66.2M$1.6M$1.5M$1.1M
FQ-6$65.0M$5.8M$4.9M$5.8M
FQ-5$56.9M$1.5M$938.0k$1.9M
FQ-4$69.0M$3.1M$1.8M$3.9M
FQ-3$58.3M$240.0k-$256.0k$686.0k
FQ-2$75.8M$6.5M$5.8M$7.1M
FQ-1$69.0M$2.2M$1.9M$2.9M
FQ0$93.8M$20.8M$16.4M$18.6M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$675.0M$122.3M
FQ-6$483.4M$118.2M
FQ-5$458.4M$119.2M
FQ-4$362.1M$120.9M
FQ-3$445.0M$120.7M
FQ-2$519.6M$120.2M
FQ-1$828.4M$122.2M
FQ0$475.3M$135.6M
PeriodOCFCapExFCFSBC
FQ-7$291.2M-$1.4M$1.1M
FQ-6$89.3M-$1.7M$5.8M
FQ-5$62.6M-$1.8M$1.9M
FQ-4$55.8M-$2.0M$3.9M
FQ-3-$14.0M-$65.0k$686.0k
FQ-2$80.5M-$252.0k$7.1M
FQ-1$455.4M-$341.0k$2.9M
FQ0$25.1M-$670.0k$18.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$122.3M
Net cash-$78.1M
Current ratio
Debt/Equity0.6
ROA0.2%
ROE1.2%
Cash conversion198.1%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Banking & Investment Services · cohort 589 companies
MetricIPEActivity
Op margin2.4%25.7% medp25 3.6% · p75 52.2%bottom quartile
Net margin2.2%21.2% medp25 4.2% · p75 45.9%bottom quartile
Gross margin81.4% medp25 46.5% · p75 95.8%
CapEx / revenue-2.2%-1.7% medp25 -4.8% · p75 -0.4%below median
Debt / equity64.0%14.8% medp25 0.1% · p75 134.4%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:52 UTC#787fddec
Market quoteclose PLN 6.80 · shares 0.03B diluted
no public URL
2026-05-10 02:18 UTC#65c154e2
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 05:51 UTCJob: b4d70251